TRATECIN Trademark

Trademark Overview


On Wednesday, April 13, 2016, a trademark application was filed for TRATECIN with the United States Patent and Trademark Office. The USPTO has given the TRATECIN trademark a serial number of 86973936. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, April 2, 2018. This trademark is owned by DAIICHI SANKYO COMPANY, LIMITED. The TRATECIN trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment and prevention of cardiovascular disease, atherosclerosis, diabetic nephropathy, stroke, heart attack, hypercholesterolemia, dyslipidemia, anemia, blood disorders, diabetes, thyroid function disease, metabolic disorders, cancer, oncological disease, metastasis, autoimmune disease, allergy, bacterial infection, viral infection, fungal infection, inflammation and inflammatory disease, musculoskeletal disorders, pain, osteoporosis, Alzheimer's disease, obesity, anorexia, urinary and kidney disease, respiratory disease; pharmaceutical preparations used as contrast agents, namely, diagnostic reagents and contrast media for medical use
tratecin

General Information


Serial Number86973936
Word MarkTRATECIN
Filing DateWednesday, April 13, 2016
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, April 2, 2018
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, January 3, 2017

Trademark Statements


Indication of Colors claimedColor is not claimed as a feature of the mark.
Description of MarkThe mark consists of "TRATECIN" shown in all CAPS.
Goods and ServicesPharmaceutical preparations for the treatment and prevention of cardiovascular disease, atherosclerosis, diabetic nephropathy, stroke, heart attack, hypercholesterolemia, dyslipidemia, anemia, blood disorders, diabetes, thyroid function disease, metabolic disorders, cancer, oncological disease, metastasis, autoimmune disease, allergy, bacterial infection, viral infection, fungal infection, inflammation and inflammatory disease, musculoskeletal disorders, pain, osteoporosis, Alzheimer's disease, obesity, anorexia, urinary and kidney disease, respiratory disease; pharmaceutical preparations used as contrast agents, namely, diagnostic reagents and contrast media for medical use

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, April 18, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameDAIICHI SANKYO COMPANY, LIMITED
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressTokyo 103-8426
JP

Party NameDAIICHI SANKYO COMPANY, LIMITED
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTokyo 103-8426
JP

Trademark Events


Event DateEvent Description
Monday, April 2, 2018ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, April 2, 2018ABANDONMENT - NO USE STATEMENT FILED
Thursday, July 13, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 11, 2017EXTENSION 1 GRANTED
Tuesday, July 11, 2017EXTENSION 1 FILED
Tuesday, July 11, 2017TEAS EXTENSION RECEIVED
Tuesday, February 28, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 3, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 3, 2017PUBLISHED FOR OPPOSITION
Wednesday, December 14, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, November 25, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, November 16, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, November 8, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, November 8, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, November 7, 2016ASSIGNED TO LIE
Wednesday, October 26, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, July 7, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, July 7, 2016NON-FINAL ACTION E-MAILED
Thursday, July 7, 2016NON-FINAL ACTION WRITTEN
Saturday, July 2, 2016ASSIGNED TO EXAMINER
Friday, May 6, 2016TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Friday, May 6, 2016TEAS VOLUNTARY AMENDMENT RECEIVED
Monday, April 18, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, April 16, 2016NEW APPLICATION ENTERED IN TRAM